These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575 [No Abstract] [Full Text] [Related]
3. Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with fraxiparine and its successful clinical use. Luzzatto G; Cordiano I; Patrassi G; Fabris F Thromb Haemost; 1996 Jan; 75(1):211-2. PubMed ID: 8713803 [No Abstract] [Full Text] [Related]
4. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis. Davenport A Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318 [No Abstract] [Full Text] [Related]
7. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment. Kelton JG Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026 [No Abstract] [Full Text] [Related]
8. Heparin-induced thrombocytopenia in critically ill patients. Warkentin TE Crit Care Clin; 2011 Oct; 27(4):805-23, v. PubMed ID: 22082515 [TBL] [Abstract][Full Text] [Related]
9. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin. Warkentin TE; Bernstein RA N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624 [No Abstract] [Full Text] [Related]
11. High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT. Warkentin TE; Sheppard JI; Linkins LA; Arnold DM; Nazy I Blood; 2018 Sep; 132(12):1345-1349. PubMed ID: 30064975 [No Abstract] [Full Text] [Related]
12. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. Warkentin TE; Sheppard JI; Moore JC; Kelton JG J Thromb Haemost; 2010 Jan; 8(1):216-8. PubMed ID: 19818000 [No Abstract] [Full Text] [Related]
14. HIT happens: diagnosing and evaluating the patient with heparin-induced thrombocytopenia. Greinacher A; Levy JH Anesth Analg; 2008 Aug; 107(2):356-8. PubMed ID: 18633006 [No Abstract] [Full Text] [Related]
15. Testing for heparin-induced thrombocytopenia antibodies. Warkentin TE; Sheppard JA Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164 [TBL] [Abstract][Full Text] [Related]
16. Improving the laboratory diagnosis of heparin-induced thrombocytopenia. Rodgers GM Am J Med; 2003 May; 114(7):609-10. PubMed ID: 12753887 [No Abstract] [Full Text] [Related]
17. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367 [TBL] [Abstract][Full Text] [Related]
18. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Levy JH; Tanaka KA; Hursting MJ Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208 [TBL] [Abstract][Full Text] [Related]